Prior experience in virology or immunology is desirable. Candidates must have experience in immunological or virological assays for BSL2 or BSL3 labs. Animal handling and experimentation is desirable. 

Ph.D or Ph.D thesis submitted or defended experience Biochemistry, Biotechnology, Stem Cell Biology and Neurobiology, Neuroscience with a strong publication record and research experience in Cell Biology, Molecular Biology and Neurobiology.

Expertise in different types of purification techniques. Sound knowledge of different column chemistry used in HPLC. Responsible for troubleshooting of instruments and their calibration

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world.

Ensure that Bulk Viral Antigen production adheres to GMP standards on the shop floor, including line clearance, dispensing, and preparation processes. Examining and approving batch records, standard operating procedures, project plans, customer verification, and APS documents.

Post Graduation in Science M.Pharm, Life Sciences, Biotech, Zoology, Botany, etc. With PG Diploma in Clinical Research is mandatory. Candidates should have at least one-year experience as Clinical Trial / Research Coordinator is mandatory.

First-class Post-Graduate degree MPharm, MS Pharm in Pharmaceutics from a recognised University or equivalent. OR 2nd Class Post-Graduate degree MPharm, MS Pharm in Pharmaceutics with PhD

Degree or Diploma in Pharmacy and Registration in CG Pharmacy Registration council.

Google PhD Fellowship students are a select group recognized by Google researchers and their institutions as some of the most promising young academics in the world. The Fellowships are awarded to students who represent the future of research in the fields listed below. Note that region-specific research areas will be listed in application forms during the application window.

Position of one Research Associate in Gates foundation funded project entitled Development of climate resilient chickpea and brassica by gene editing. Candidates having Ph.D. degrees in Plant Sciences, Life Sciences and Biochemistry or equivalent subject.

R&D project entitled Development of a Non-Invasive Spectroscopic Device for The Assessment of Urinary Bladder Cancer UBC and Large-Scale Clinical Trial for Early Diagnosis. Post Graduate Degree First Class in any branch of Life Sciences or related subjects.

one Senior Project Assistant in the ICMR sponsored project entitled Development and Evaluation of Recombinant anti-HER2 ScFv for Targeted Breast Cancer Therapy Production, Characterization, Therapeutic Efficacy Analysis through in vitro and in vivo studies.

First Class Masters degree in Molecular Biology or Biotechnology, Medical Biochemistry, Applied Biology, Life Sciences from a recognized university with 4 years of experience in relevant area.

M.Sc, MS, M.Tech in Biology or related discipline. The candidate should have experience with rodent behavioural experiments, stereotaxic surgery, rodent brain dissection, immunohistochemistry, western blot and other molecular biological techniques.

To be an integral part of an antibody development team with a focus on performance and improve customer outcomes through validation of cell culture workflows, reagents, and consumables.

Facility located at Vadodara, Gujarat Location and has been designed to support scale up and commercial supply of Injectable Formulations.

In a paper in the Journal of Diabetes Science and Technology, researchers at Stevens Institute of Technology offer a new approach: a data-sparse model capable of accurately predicting individual glycemic responses with no need for blood draws, stool samples, or other unpleasant testing. The key to their approach? Keeping track of what people actually eat.

Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy in patients with autoimmune conditions. Patient recruitment for the phase 1 trial will begin soon.

Sandoz the global leader in generic and biosimilar medicines announced the filing of an antitrust lawsuit in the US against Amgen, Inc. , for extending and entrenching the dominant market position of its blockbuster medicine, Enbrel etanercept, first approved by the US Food and Drug Administration in 1998.